Business Description
GeoVax Labs is a US-based biotech company focused on developing vaccines and treatments for serious infectious diseases and cancer. Its pipeline spans conditions ranging from COVID-19, HIV, and Ebola to solid tumor cancers, with several candidates already in clinical trials and others in earlier stages of research. The company works alongside prominent partners including the National Institutes of Health and the US Department of Defense. Founded in 1988 and based in Smyrna, Georgia, GeoVax applies its own proprietary technology platforms across all of its programs.
